CREATE Medicines | RoundOS

Weekly digest by email

Loading companies…

CREATE Medicines | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
May 14, 2026	Series B	$122M	Alexandria Venture Investments — Role not disclosedARCH Venture Partners — Role not disclosedHatteras Venture Partners — Role not disclosedNewpath Partners — Role not disclosed

Investors

Alexandria Venture InvestmentsSeries B ARCH Venture PartnersSeries B Hatteras Venture PartnersSeries B Newpath PartnersSeries B

Coverage

May 14, 2026CREATE Medicines · Series B

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

createmedicines.com ↗